Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
May 4, 2021	EFFECT	EFFECT	View HTML 9999999995-21-001780.pdf 9999999995-21-001780.rtf 9999999995-21-001780.xls
Apr 30, 2021	CORRESP	CORRESP	View HTML 0000320017-21-000058.pdf 0000320017-21-000058.rtf 0000320017-21-000058.xls
Apr 28, 2021	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000320017-21-000056.pdf 0000320017-21-000056.rtf 0000320017-21-000056.xls
Apr 28, 2021	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000320017-21-000055.pdf 0000320017-21-000055.rtf 0000320017-21-000055.xls
Apr 6, 2021	UPLOAD	UPLOAD	View HTML 0000000000-21-004148.pdf 0000000000-21-004148.rtf
Apr 1, 2021	S-3	Simplified registration form	View HTML 0000320017-21-000050.pdf 0000320017-21-000050.rtf 0000320017-21-000050.xls
Mar 19, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-21-000046.pdf 0000320017-21-000046.rtf 0000320017-21-000046.xls
Feb 25, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-21-000042.pdf 0000320017-21-000042.rtf 0000320017-21-000042.xls
Feb 25, 2021	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000320017-21-000043.pdf 0000320017-21-000043.rtf 0000320017-21-000043.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 24, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001104659-21-027247.pdf 0001104659-21-027247.rtf 0001104659-21-027247.xls